SUMMARY
Compromised sleep and increased sympathetic nervous system (SNS) activity are implicated in the pathogenesis of, and disparities in, cardiovascular disease. Parasympathetic dominance during sleep may be important for cardiovascular health. Sleep and autonomic balance influence immune activity, which impacts atherogenesis. We evaluated relationships between autonomic balance during sleep and morning levels of the immune activating cytokines, C-reactive protein (CRP) and interleukin (IL)-6. Ninety-four (59 female) young adult African Americans without medical conditions and substance use disorders spent 2 consecutive nights in a clinical research unit for sleep recordings and blood drawing on awakening. Cardiac tracings from the second sleep recording were analysed for heart rate variability (HRV). Body mass index was the only non-HRV measure correlated with cytokine levels. Indicators of SNS activity for the presleep, and first non-rapid eye movement (REM) and REM sleep periods were correlated independently with morning IL-6 levels. Altered autonomic balance during sleep may be a modifiable factor that influences immune activation.
IN TROD UCTI ON
Compromised sleep (e.g. short sleep duration, insomnia, sleep apnea) is associated with adverse health consequences, including obesity (Cappuccio et al., 2008) , diabetes (Ayas et al., 2003a,b; Beihl et al., 2009) , hypertension and cardiovascular disease (CVD) (Ayas et al., 2003a,b; Phillips and Mannino, 2007) and early mortality (Gallicchio and Kalesan, 2009; Kripke et al., 2002) . These conditions affect African Americans disproportionately (Center for Disease Control and Prevention, 2011) . African Americans are more likely to report short sleep duration than whites, and this appears to be influenced by living in high-density urban environments (Hale and Do, 2007) .
Autonomic balance is determined by the relative contributions of the parasympathetic nervous system (PNS) and the sympathetic nervous system (SNS). The contribution of the SNS increases during exercise and stress. Persistent increases in SNS activity is an important contributor to the negative effects of stress on cardiovascular health (Guzzetti et al., 2002; Kohara et al., 1995; Phillips et al., 2000) .
During sleep, particularly non-rapid eye movement (NREM) stages, there is an increase in PNS and decrease in SNS activity (Bonnet and Arand, 1997; Burgess et al., 2004; Trinder et al., 2001) . Evidence of adverse consequences from shifts towards PNS dominance during sleep being compromised includes observations of increased nocturnal SNS activity with blood pressure non-dipping, which is a well-established cardiovascular risk factor (Kohara et al., 1995) , the association of sleep apnea with increased nocturnal SNS activity and hypertension (Narkiewicz and Somers, 1997) and observations of blunted night-time reduction of SNS activity in individuals with histories of myocardial infarction (Guzzetti et al., 2002) . These associations suggest that PNS dominance during sleep may be important towards maintaining cardiovascular health.
Heart rate variability (HRV) is a non-invasive method that analyses patterns in time-series of consecutive R-peaks in the cardiac cycle, and is used to assess autonomic nervous system (ANS) activity (Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996) . Evidence that the shift during sleep towards PNS dominance can be compromised with insomnia and stress includes a study by Bonnet and Arand (1998) , in which the HRV index of parasympathetic tone (normalized high frequency, nHF) was reduced among participants with ª 2017 European Sleep Research Society insomnia, who showed increased low-frequency/highfrequency (LF/HF) ratios, the standard index of SNS activity, compared with normal sleepers. Our group examined nocturnal ANS in post-traumatic stress disorder (PTSD) and resilience (Kobayashi et al., 2014) and found greater nHF power with resilience and a strong positive relationship between sleep duration and nHF and negative relationship to LF/HF in the resilient group, but not in the PTSD group.
Sympathetic nervous system influences on immune activity is now considered an important mechanism by which sustained SNS activity affects cardiovascular health adversely (Marvar et al., 2011) . Immune activation is often indexed by blood levels of proinflammatory cytokines, including interleukin (IL)-6, IL-1, C-reactive protein (CRP) and tumour necrosis factor (TNF)-a. Elevated levels of these cytokines have been associated with decreased HRV (Haarala et al., 2011) and increased risk of cardiovascular and metabolic disease (Cesari et al., 2003; Pai et al., 2004) . In a recent comprehensive review and meta-analysis of investigations relating sleep duration, sleep disturbance and experimental sleep deprivation with immune markers, Irwin et al. (2015) concluded that the evidence relates sleep disturbance and sleep duration to IL-6 and CRP levels (and not TNF-a).
Given the associations of disturbed or altered sleep, increased SNS activity and elevated proinflammatory cytokine blood levels (all of which have been associated independently with cardiovascular disease risk), we hypothesized that ANS activity during sleep would contribute to sleep's effect on immune activity. We evaluated this hypothesis by measuring CRP and IL-6 from morning blood samples and relating them to sleep measures, including HRV from the previous night, in young adult, urban-residing African Americans, a population that is demographically at increased risk for future cardiovascular disease.
METHOD Participants and procedure
Participants in this study were the subsample of young adult African Americans who had completed a protocol consisting of two PSG recordings and blood drawing in the morning after the second PSG recording as a part of a larger study evaluating relationships of sleep, stress and nocturnal blood pressure. Participants were recruited from the Washington DC metropolitan region through flyers and referrals from previous participants. During initial telephone and in-person evaluation, participants were screened for exclusionary criteria including: body mass index (BMI) ≥ 40, more than five cups of coffee per day or equivalent levels with any other caffeinated beverages, >20 cigarettes/day, >14 alcoholic drinks per week for men, more than seven drinks per week for women, chronic medical conditions that can affect blood pressure or sleep and required continuous medication use, severe psychiatric illnesses (psychotic disorders, bipolar disorder, severe recurrent depression) and habitual bedtime and rise time after 02:00 and 10:00 hours, respectively, or habitual napping >1 h day
À1
. Individuals who were eligible for the study were invited to the clinical research unit at Howard University Hospital, and after participants were informed further about the study procedure they signed informed consent documents approved by the Howard University Institutional Review Board.
A total of 543 participants completed a self-report survey packet, including demographics and health questionnaires and a measure of PTSD symptoms. One hundred and eightyfive participants who completed self-report surveys were selected to participate in the laboratory phase. The selection was made to over-sample participants with probable PTSD and balance for gender and community representation (Mellman et al., 2015) . All participants were assessed with the clinician-administered PTSD scale (CAPS). We defined subthreshold PTSD (DSM-IV) as meeting two of the three diagnostic symptom clusters. The laboratory phase included a diagnostic interview for psychiatric disorders, urine screening, height and weight measurement and two consecutive overnight PSG recordings in the clinical research unit. Additional exclusionary criteria, including sleep breathing disorder, positive urine toxicology or observed intoxication, were assessed during the laboratory phase. Of the 185 participants selected, 104 provided a blood sample. Participants were excluded due to positive urine toxicology (n = 2) and other protocol violations (n = 2) and PSG data technical problems (n = 6); therefore, this analysis includes 94 participants (59 females; 35 males). Participant characteristics are presented in Table 1 Measures
Polysomnography (PSG)
Two consecutive overnight PSG recordings in the Clinical Research Unit were completed, with the first night being for apnea screening and laboratory accommodation. Participants who had an apnea hypopnia index greater than 10 were excluded from the study. Recordings were collected using an Embla (Denver, CO, USA) titanium portable unit and included bilateral frontal, central and occipital leads, two electro-oculograms and chin electromyograms. Electrocardiogram data were imported to LabChart Pro (ADinstruments, Colorado Springs, CO, USA) and inspected visually on a computer monitor to confirm or correct identification of R-peaks. Segments with ectopic beats or artefacts that did not allow for R-peak identification were excluded. The Lomb periodogram (Clifford and Tarassenko, 2005; Lomb, 1976) was performed to compute frequency domain HRV parameters, including LF power (0.04-0.15 Hz), HF power (0.15-0.4 Hz) and LF/HF ratios for each non-overlapping 5-min epoch. For the purpose of this study, HRV parameters were computed for the 5-min period prior to sleep onset and the first and last REM and NREM sleep periods that lasted ≥5 min.
IL-6 and CRP
Blood samples were obtained from participants by venipuncture within 15 min of awakening in the morning after the second night of PSG recording. After clotting, blood samples were centrifuged and serum was collected and stored in a freezer at À70°C. IL-6 and CRP levels were detected and quantified using enzyme-linked immunosorbent assays (ELISA) (Quantikine HS ELISA human IL-6 immunoassay kit; R&D Systems, Minneapolis, MN, USA and high-sensitivity C-reactive protein ELISA kit; Calbiotech, Spring Valley, CA, USA) and a microplate spectrophotometer.
Data analyses
All data were analysed using SPSS version 22.0 (IBM, Armonk, NY, USA) and alpha = 0.05 (two-tailed) was applied for all analyses. Data were checked for normality. Log-transformations were performed on IL-6 and CRP levels and presleep LF/HF, first and last NREM LF/HF and first and last REM LF/ HF (Figs 1-3 ). Pearson's correlations were computed between IL-6, CRP, HRV parameters, sleep measures and participant characteristics. Hierarchical regression analyses were conducted to examine whether HRV parameters that were correlated significantly with IL-6 or CRP continued to predict IL-6 or CRP after controlling for BMI, which was 
RESUL TS
Correlation coefficients between cytokines, HRV parameters, sleep measures and participant characteristics are presented in Table 2 . BMI was the only clinical and non-HRV measure that was correlated significantly with IL-6 and CRP. In addition to the absence of a relationship to PTSD severity, t-tests did not reveal differences between IL-6 and CRP as a function of PTSD diagnosis (PTSD = 25, no PTSD = 69; t (1,92) = 0.953; P = 0.343; t (1,92) = 1.403, P = 0.164. Normalized HF was also not correlated with IL-6 or CRP. IL-6 was correlated significantly positively with LF/HF during the presleep, first NREM and first REM periods (see Figures 1-3) . CRP was correlated significantly positively with first REM LF/ HF. LF/HF during the last NREM and REM sleep periods were not correlated with either IL-6 or CRP. The hierarchical regression analyses shown after controlling for BMI, presleep, first NREM and REM LF/HF continued to be associated significantly with morning IL-6 levels (b = 0.252, P = 0.019, DR 2 = 0.063; b = 0.260, P = 0.010, DR 2 = 0.067; b = 0.204, P = 0.044, DR 2 = 0.040, respectively), while LF/HF during the first REM period was no longer associated significantly with CRP (b = 0.166, P = 0.098, DR 2 = 0.027). SDRR was correlated only with IL-6 during the presleep period. When we added SDRR to the regression model, it did not account significantly for additional variance beyond BMI.
DISCUSSION
The present study was conducted to examine relationships between nocturnal autonomic nervous system activity during sleep, evaluated by HRV indices and morning levels of the proinflammatory biomarkers IL-6 and CRP. Findings of this study show that LF/HF ratios from presleep, first NREM and first REM, but not from the last NREM or REM sleep periods, were significant predictors of IL-6 after controlling for BMI. The nature of these relationships is consistent with the halflives reported for the respective cytokines, 2-4 h for IL-6 and 20 h for CRP (Marino and Giotta, 2008) . Thus, effects of autonomic activity on IL-6 secretion during the first half of the sleep period would probably be reflected by morning levels, whereas effects on longer-enduring CRP would not necessarily be evident the next morning. Our findings are consistent with the emerging research linking immune activation to SNS arousal (Marvar et al., 2011) . Given the absence of a relationship to standard PSG measures in our study, autonomic arousal may be a mechanism underlying the influence of compromised sleep on immune activation. The possible influence of nocturnal autonomic activity influencing immune activation is also supported by Irwin et al.'s finding of a relationship between nocturnal circulating noradrenaline and compromised immune function with insomnia (Irwin et al., 2003) . These findings suggest the possibility that decreasing sympathetic nervous system activity prior to sleep could reduce immune activation. It would be of interest to determine if recent popular approaches from complementary medicine such as mindfulness, as well as increased daytime physical activity, influence this mechanism favourably. Study limitations include utilizing only a single blood drawing and measurement of two cytokines, albeit the two Figure 3 . Scatterplot for first rapid eye movement (REM) lowfrequency/high-frequency (LF/HF) and interleukin (IL)-6. First REM LF/HF and IL-6 were log-transformed. *P < 0.05; **P < 0.01; ***P < 0.001; n varied between 75 and 94 due to missing data. Gender code: 0 = women, 1 = men. LF/HF, low frequency to high frequency ratio; SDRR, standard deviation of R-R interval; TST, total sleep time; REM, rapid eye movement; NREM, non-REM; CAPS, clinician-administered PTSD scale.
ª 2017 European Sleep Research Society most consistently linked to sleep (Irwin et al., 2015) . Sleep was recorded and samples were obtained in a clinical laboratory setting in which sleep and related processes can vary from naturalistic settings. Further, interpretation of HRV parameters used in this study needs to be conducted with caution, as it has been suggested that LF power is also contributed by the PNS (Reyes Del Paso et al., 2013) . In addition to this, menstrual cycle was not controlled for, as this may have had an impact upon autonomic nervous system balance. The present study focused on young adult African Americans, which may limit generalizability to other populations; however, the study population is of high significance, as the participants are demographically at elevated risk for adverse cardiovascular outcomes and interventions could have preventive benefits during early adulthood. The possibility suggested by our preliminary findings, that autonomic activity during sleep influences cytokine activity, requires confirmation by more comprehensive evaluations, as there is still much variance that is not explained. Prospective studies are needed in order to evaluate nocturnal autonomic nervous system activity as a modifiable contributor to atherogenesis. The significance of further establishing such relationships is underscored by elevated autonomic arousal prior to sleep onset and during the early hours of sleep being a potentially modifiable contributor to processes that accelerate atherogenesis and related cardiovascular dysfunction in populations at risk.
